Guardant Infinity is a novel technology platform that delivers multiomic insights
to power multiple precision oncology
applications.

Quantify cancer

Monitor and measure cancer
across the continuum of care

Methylation-based
quantification of tumor fraction
to measure disease burden

Characterize cancer

Power the discovery of novel biomarkers with breakthrough multiomic insights

Liquid and tissue profiling that unlocks a multidimensional view of cancer with genomic, epigenomic, and RNA-based fusion data*

*RNA-based fusion data are only for tissue profiling,
not liquid testing.

Get a more
complete view of cancer with Guardant Infinity.